|
We are a leading Supplier & Manufacturer of Specialty Division such as Acth-Biotech (Corticotrophin Carboxymethylcellulose), Ambilip (Liposomal Amphotericin B Injection 50 Mg Lyophilized), Azitec (Azithromycin Tablets 500 mg), Azitec (Azithromycin For Injection 500 Mg), Azitec (Azithromycin Tablets 250 Mg), Azom (Aztreonam For Injection USP 500 Mg) and many more items from India.
|
Azitec 500MG | | Azithromycin For Injection 500 mg
Indications:
Community Acquired Pneumonia Pevlic Inflammatory Diseases
Dosage :
| Indications | Recommended Dose/Duration of Therapy | | Community-acquired pneumonia (mild severity) Pharyngitis/fonsillitis (second line therapy) Skin/Skin structure (uncomplicated) | 500 mg IV as a single dose on Day 1, followed by 500mg once daily on Days 2 through 5 | | Pelvic Inflammatory diseases | 500mg IV as a single dose for 1-2 days followed by 250mg tablet once daily for seven days. |
Infants and Children : 10-30 mg/kg once a daily for 3 days. Renally Impaired Patients : No dosage adjustment required.
Packing : 5 Vials of 500 mg
| 
 | | |
| Azitec 500mg | 
 | Azithromycin Tablets 500 mg
Indications: - Acute Exacerbation Of Chronic Bronchitis
- Acute Bacterial Sinusitis
- Community Acquired Pneumonia
- Pharyngitis/Tonsillitis
- Uncomplicated SSTI
- Urethritis / Cervicitis
- Genital Ulcer Disease
- Uncomplicated skin & skin structure infections
Dosage
| Indications | Recommended Dose/Duration of Therapy | | Community-aquired pneumonia (mild severity) Pharyngitis/fonsillitis (second line therapy) Skin/Skin structure (uncomplicated) | 500 mg as a single dose on Day 1, followed by 250mg once daily on Days 2 through 5 | | Acute baterial exacerbations of chronic obstructive pulmonary disease (mild to moderate) | 500mg OD X 3 days OR 500mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5. | | Acute bacterial sinusitis | 500 mg OD X 3 days | | Genital ulcer diseas (chancroid) | Single 1 gram dose | | Non-gonoccocal urethritis and cervicitis | Single 1 gram dose | | Gonococcal urethritis and cervicitis | Single 2 gram dose |
Infants and Children : 10-30 mg/kg once a daily for 3 days. Oral Dosage : 500 mg 3-4 times a day for 3-5 days. Really Impaired Patients : No dosage adjustment required.
Packing : 10 Strips of 3 Tablets
| |
Otide (Octreotide Acetate Injection 50 mcg and 100 mcg) | | Indications :
-
Emergency management of bleeding esophageal varices -
Acromegaly -
Post high risk pancreatic surgery -
Gastro-entero-pancreatic (GEP) endocrine tumors -
Radiotherapy/Chemotherapy induced diarrhoea -
Chylothorax
Dosage : Adult : 50-100 mcg S.C. inj. TID or BD.
Maximum : 2000 mcg.
Really Impaired Patients : In patients with renal failure requiring dialysis, the starting dose should be 10 mg every 4 weeks.
Packing : | 50 mcg | 1 Ampoules of 50 mcg/ml | | 100 mcg | 1 Ampoules of 100 mcg/ml |
|  | | |
| Danozec (Danazol Capsules USP 50 mg, 100 mg and 200 mg) |  | Indications :
-
Endometriosis associated infertility -
Benign breast disease (chronic cystic mastitis, mastodynia) -
Menorrhagia -
Gynaecomastia -
Primary constitutional precocious puberty -
Hereditary Angioedema -
Thrombocytopenic purpura
Dosage : Female : Endometriosis and associated infertility : 200-800 mg daily in divided doses. Dosage should be increased (but not to exceed 800mg per day). Benign breast disease (chronic cystic mastitis, virginal breast hyperplasia, mazoplasia, mastodynia) : 100-400 mg daily in divided doses. Menorrhagia : 200 mg daily for 12 weeks. Exceptional cases may need up to 400 mg daily. Male : Gynaecomastia : 200-800 mg daily, in divided doses.
Children: Primary constitutional precocious puberty : 100-400 mg daily, according to patient's age and weight.
Really Impaired Patients : Not known, administer with caution. Packing : | 50 mg | 1 Strips of 10 Capsules | | 100 mg | 1 Strips of 10 Capsules | | 200 mg | 1 Strips of 10 Capsules |
| |
Levoslog (Levofloxacin Tablets 250mg, 500mg and 750mg) | | Indications : -
Community acquired pneumonia -
Nosocomial Pneumonia -
Acute Bacterial Sinusitis -
Complicated skin and skin structure infection -
Chronic bacterial Prostatitis -
Complicated urinary tract infection -
Acute Pyelonephritis Dosage : Dosage in Adult Patients with Normal Renal Function (creatinine clearance ≥ 50mL/min). | Type of Infections | Dosed Every 24 hours | Duration (days) | | Nosocomial Pneumonia | 750mg | 7-14 | | Community-acquired Pneumonia | 750mg | 7-14 | | Chronic Bacterial Prostatits | 500mg | 28 | | Uncomplicated Urinary Tract Infection | 250mg | 3 | | Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) | 750mg | 5 | Really Impaired Patients : | CrCl(ml/min) | Recommended Dosage | | >/=50 | No adjustment required | | 20-49 | 500mg X 1,then 250mg q 24h | | 10-19 | 500mg X 1, then 250m q48h | | <10 | 500mg X 1 then 125-250mg q48h | Packing :
| 250 mg | 1 Strips of 10 Tablets | | 500 mg | 1 Strips of 10 Tablets | | 700 mg | 1 Strips of 5 Tablets |
|  | | |
| Iron Polymaltose Complex Chewable Tab. 50 mg and 100 mg |  | Indications :
-
Iron deficiency anaemia including Macrocytic anaemia -
Anaemia due to excessive haemorrhage -
Anaemia associated with infections -
Anaemia associated with malignant disease -
Prevention and treatment of iron deficiency anaemia before, during and after pregnancy and during lactation -
For prophylactic therapy of iron deficiency Dosage :
Dosage and duration of therapy depend upon the extent of iron deficiency. The daily dose can be divided into separate doses or can be taken at one time during or after meal. | Age Group | Dosage | | Adults | 1 Tablet once a day | | Children | 1 Tablet once a day | | Lactating women | 1-2 Tablet once a day | | Pregnant women | 1-3 Tablet once a day | Really Impaired Patients : Not known, administer with caution. Packing :
| 50 mg | 1 Strips of 10 Tablets | | 100 mg | 1 Strips of 10 Tablets |
| |
Follitec (Urofollitropin for Injection BP 75 and 150 IU) | | Indications :
-
For stimulation of follicular growth in infertile women. -
For single follicular development in hypothalamic pituitary dysfunction. -
To stimulate the development of multiple follicular oocytes . Dosage : Females with hypothalamic- pituitary dysfunction who has either oligomenrrhoea or amenorrhoea : 75 - 150 IU Urofollitrophin daily and may be increased or decreased by up to 75 IU/day at 14 days intervals.
Females undergoing superovulation for in-vitro fertilization & other assisted conception method : For superovulation 150-225 IU Urofollitrophin should be given daily within 2 or 3 days of the beginning of the cycle.
Renally Impaired Patients : Not known, administer with caution. Clinical Pharmacology: Infertility Drug Packing : | 75 UI | 1 Vials of 75 IU | | 150 UI | 1 Vials of 150 IU |
|  | | |
| Menotrophin for Injection BP 75 IU and 150 IU |  | Indications :
Female Follicle Stimulation in IVF
Male Infertile patients with oligoanovulation
Dosage :
Initail Dose : 225 Units
Male Infertile patients with oligoanovulation : 150 Units daily for the first 5 days of treatment for patients who have received GnRH agonist or antagonist pitutary supression.
Renally Impaired Patients : Not known, administer with caution. Packing : | 75 IU | 1 Vials of 75 IU | | 150 IU | 1 Vials of 150 IU |
| |
Somatostatin for Injection 250 mcg and 3 mg | | Indications :
-
Acute severe gastrointestinal hemorrhage, resulting from gastric or duodenal ulcers, haemorrhagic gastritis and oesophageal varices -
Treatment of intestinal, biliary and pancreatic fistulae -
Symptomatic treatment of excessive secretion from endocrine tumors of the gastrointestinal tract -
Treatment of postoperative complications and prophylaxis following pancreatic surgery -
Co adjuvant treatment in diabetic ketoacidosis
Dosage : Initial Dose : 250 mcg as bolus over 3 to 5 minutes. Maintenance Dose : A continual infusion of 3.5 mcg/kg/hr. i.e. one 3mg vial given over 12 hr. The continual administration should last a minimum of 48 hr and a maximum of 120 hr. (5 days).
Coadjuvant treatment in diabetic ketoacidosis : In patients with ketoacidosis infusion of 100-500mcg/hr of somatostatin given concurrently with a bolus insulin injection.
Packing :
| 250 mcg | 1 Vials of 250 mcg | | 3 mg | 1 Vials of 3 mg |
|  | | |
| Corticotrophin Carboxymethyl Cellulose Injection | 
 | Acth-Biotech (Corticotrophin Carboxymethylcellulose Injection 73 300 IU)
Indications : -
Is indicated in conditions where a stimulatory effect of ACTH on the adrenal cortex is desired. -
Infantile spasm -
Bronchial Asthma -
Rheumotoid arithritis -
Multiple sclerosis -
Myasthenia gravis -
Ulcerative colitis -
Chronic active liver disease -
Hay fever -
Severe dermatitis -
Hemorrhage -
Collagen diseases -
Septicemia -
Nephrotic syndrome -
Severe stress conditions -
Adrenal function test -
Lupus erythematosus disseminatus
Dosage
It is preferable given SC but it may also be administered IM. Long term treatment Usual Dose : 15-30 IU (0.25-0.5ml) SC every two days for protracted treatment. Max. Dose : 60IU (1ml) daily or every two days. The same effect as with 15 IU daily is also achieved with 30 IU every two days or 60 IU twice weekly. In severe dermatological disorders : 60 IU or more daily. Infantile spasm : 20 IU IM daily for 2 weeks. Max. Dose : 30 IU and then 40 IU IM for additional 4 weeks.
Short Term treatment Multiple Sclerosis, Myasthenia Gravis and Ulcerative Colitis : The dosage in short term or initial treatment may vary considerably, daily dose of up to 120 IU (2ml) subcutaneously for intensive treatment. Renally Impaired Patients : Administer with caution.
Packing : 5 Vials of 60 IU/ml
| |
Ambilip 50MG | | Liposomal Amphotericin B Injection 50 mg Lyophilized
Indications : - Treatment of Cryptococcal Meningitis in HIV infected patients
- Treatment of patients with Aspergillus species, Candida species and/or Cryptococcus species infections refractory to amphotericin B deoxycholate
- In patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate
- Treatment of visceral leishmaniasis, in immuno-compromised / immunocompetent patients
- Empirical therapy in febrile neutopenic patients with presume fungal infection
Dosage : | Indication | DOSAGE | | For systemic mycoses | 3-5 mg/kg/day infusion over 120 mins. | | For prophylaxis against invasive fungal infections in liver transplant recipients | 1 mg/kg/day for five successive days followinf transplantation. | | In HIV-associated disseminated cryptococcosis | 6 mg/kg/day infusion approx. 120 mins. | | Visceral leishmaniasis (immunocompetent patients) | 3 mg /kg/day on days 1 through 5, 14 & 21. | | Visceral leishmaniasis (immunocompromised patents) | 4mg/kg/day on day one through 5, 10, 17, 24, 31 & 38. | | For empirical treatment of presumed fungal infection of febrile neutropaenic patients | 3 mg/kg/day infusion over 120 mins. |
Renally Impaired Patients : Not known, administer with caution. Packing : 5 Vials of 50 mg
| 
 | | |
| Azitec (Azithromycin Tablets 250 MG) | 
 | Indications: - Acute Exacerbation Of Chronic Bronchitis
- Acute Bacterial Sinusitis
- Community Acquired Pneumonia
- Pharyngitis/Tonsillitis
- Uncomplicated SSTI
- Urethritis / Cervicitis
- Genital Ulcer Disease
- Acute Otitis Media
- Pevlic Inflammatory Diseases
- Sexually Transmitted Infections
Dosage : | Indications | Recommended Dose/Duration of Therapy | | Community-acquired pneumonia (mild severity) Pharyngitis/fonsillitis (second line therapy) Skin/Skin structure (uncomplicated) | 500 mg as a single dose on Day 1, followed by 250mg once daily on Days 2 through 5 | | Acute bacterial exacerbation of chronic obstructive pulmonary disease (mild to moderate) | 500mg OD X 3 days OR 500mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5. | | Acute bacterial sinusitis | 500 mg OD X 3 days | | Genital ulcer diseas (chancroid) | Single 1 gram dose | | Non-gonoccocal urethritis and cervicitis | Single 1 gram dose | | Gonococcal urethritis and cervicitis | Single 2 gram dose | Infants and Children : 10-30 mg/kg once a daily for 3 days.
Oral Dosage : 500 mg 3-4 times a day for 3-5 days.
Renally Impaired Patients : No dosage adjustment required. Packing : 10 Strips of 6 Tablets
| |
Azom 500MG | | (Aztreonam For Injection USP 500 mg)
Indications : -
Intra-abdominal infections -
Urinary Tract Infections -
Septicemia -
Lower Respiratory Tract Infections -
Skin & soft tissue infections - Bone & Joint infections
- Gynecological infections
- Surgical infections
Dosage : Adult : 500 mg to 2g every 8 or 12 hrs.
Maximum Dose : 8g/day.
Pediatric : 30–90 mg/kg every 6 – 8 hrs.
Maximum Dose : 120 mg/ kg/day.
Renally Impaired Patients : After an initial loading dose of 1 to 2 grams, the dose should be halved in patients with estimated creatinine clearance between 10 and 30 mL/min. Packing : 10 Vials of 500 mg
| 
 | | |
| Azom (Aztreonam For Injection USP 1000 Mg) | 
 | Indications : -
Intra-abdominal infections -
Urinary Tract Infections -
Septicemia -
Lower Respiratory Tract Infections -
Skin & soft tissue infections -
Bone & Joint infections Dosage : Adult : 500 mg to 2g every 8 or 12 hrs.
Maximum Dose : 8g/day.
Pediatric : 30–90 mg/kg every 6 – 8 hrs.
Maximum Dose : 120 mg/ kg/day.
Renally Impaired Patients : After an initial loading dose of 1 to 2 grams, the dose should be halved in patients with estimated creatinine clearance between 10 and 30 mL/min. Packing : 10 Vials of 1000 mg
| |
Biolac 100ML | | (Lactulose Solution USP 100 ml)
Indications : Dosage : Adult : 15-30 ml 3-4 times a day.
Pediatric : 5-15 ml 1-2 times a day.
Hepatic Encephalopathy : Start with 30-40ml, 3 to 4 times daily.
Renally Impaired Patients : No dosage adjustment required. Packing : 50 Bottles of 100 ml
| 
 | | |
| Biollac (Lactulose Solution USP 200 Ml) | 
 | Indications : -
Constipation (Surgery, Pregnancy) -
Hepatic Encephalopathy -
Salmonellosis -
Renal Insufficiency -
Pre Surgical Evacunation, Diagnostic Aid Dosage : Adult : 15-30 ml 3-4 times a day.
Pediatric : 5-15 ml 1-2 times a day.
Hepatic Encephalopathy : Start with 30-40ml, 3 to 4 times daily.
Renally Impaired Patients : No dosage adjustment required. Packing : 25 Bottles of 200 ml
| |
Cefoprit 1.5g | | (Cefuroxime Sodium For Injection USP 1.5 g)
Indications : Dosage : Adult : Parenteral : 750 mg to 1.5 g every 8 hours for 5 to 10 days.
Paediatric : 50-100mg/kg/day BID.
Really Impaired Patients : Oral | CrCl (ml/min) | Recommended Dosage | | >20 | No changes(750 mg to 1.5 gm IV q8h) | | 10-20 | 750 mg q12h | | <10 | 750 mg q24h | Packing : 10 Strips of 1.5 g
| 
 | | |
| Cefoprit 500MG | 
 | (Cefuroxime Axetil Tablets USP 500 mg)
Indications : -
Upper Respiratory Tract Infections -
Uncomplicated urinary Tract Infections -
Uncomplicated skin & soft Tissue Infections - Pharyngitis / tonsilitis
- Acute bacterial otitis media
- Acute bacterial maxillary sinusitis
- Acute bacterial exacerbation of chronic bronchitis & secondary bacterial infections of acute bronchitis
- Uncomplicated gonorrhea, urethral & endocervical
Dosage : Adult :
Oral : 250 mg to 500 mg BID for 10 days.
Paediatric : 30-100mg/kg/day BID / QID.
RenallyImpaired Patients : Oral | CrCl (ml/min) | Recommended Dosage | | >10 | No changes | | <10 | Give 250mg q24h. | Packing : 5 Strips of 4 Tablets
| |
Cefoprit (Cefuroxime Axetil Tablets USP 250 Mg) | | Indications : -
Upper Respiratory Tract Infections -
Urinary Tract Infections -
Skin & Soft Tissue Infections -
Bone & Joint Infections due to S.aureus Dosage : Adult :
Parenteral : 750 mg to 1.5 g every 8 hours for 5 to 10 days.
Oral : 250 mg to 500 mg BID for 10 days.
Paediatric : 30 - 100mg/kg/day BID / QID.
Really Impaired Patients : Oral | CrCl (ml/min) | Recommended Dosage | | >10 | No changes | | <10 | Give 250mg q24h. | Packing : 5 Strips of 4 Tablets
| 
 | | |
| Cefoprit (Cefuroxime Sodium For Injection USP 750 Mg) | 
 | Indications : -
Upper Respiratory Tract Infections -
Urinary Tract Infections -
Skin & Soft Tissue Infections -
Bone & Joint Infections due to Saureus Dosage : Adult :
Parenteral : 750 mg to 1.5 g every 8 hours for 5 to 10 days.
Oral : 250 mg to 500 mg BID for 10 days.
Paediatric : 30 - 100mg/kg/day BID / QID.
Renally Impaired Patients : Oral | CrCl (ml/min) | Recommended Dosage | | >20 | No changes(750 mg to 1.5 gm IV q8h) | | 10-20 | 750 mg q12h | | <10 | 750 mg q24h | Packing : 10 Strips of 750 Tablets
| |
Cefor 1g | | (Cefpirome Sulphate 1 g)
Indications : Complicated Urinary Tract Infections. Upper & Lower Respiratory Tract Infections. Septicaemia, Bacteremia. Infections in Neutropenic patients. Skin & soft tissue infections.
Dosage :
Adult : 1-2gm BID.
Paediatric : 10mg/kg BID.
Really Impaired Patients :
| CrCl (mL/min) | Severe infection | Life threatening infection | | >50 | 1 g BID | 2 g BID | | ≤ 50 | 1 g loading dose | 2 g loading dose | | 50-20 | 0.5g BID | 1 g BID | | 20-5 | 0.5g daily + .25g | 1 g once daily | | <5 (haemodialysis patients) | Immediately after dialysis | 1 g daily + .5g immediately after dialysis | Packing : 10 Vials of 1 g
| 
 | | |
| Cefor (Cefpirome Sulphate 10.5G) |  | Indications :
- Urinary Tract Infections.
- Lower Respiratory Tract Infections.
- Infections in Immunocompromised patients.
Dosage :
Adult : 1-2gm BID.
Paediatric : 10mg/kg BID.
Renally Impaired Patients :
| CrCl (mL/min) | Severe infection | Life threatening infection | | >50 | 1 g BID | 2 g BID | | ≤ 50 | 1 g loading dose | 2 g loading dose | | 50-20 | 0.5g BID | 1 g BID | | 20-5 | 0.5g daily + .25g | 1 g once daily | | <5 (haemodialysis patients) | Immediately after dialysis | 1 g daily + .5g immediately after dialysis | Packing : 10 Vials of 0.5 g
| |
Choriotec 10000 IU | | (Chorionic Gonadotrophin For Injection BP 10000 IU) Indications : Female : Ovulation induction
Male : Hypogonadotropic hypogonadism Prepubertal Cryptorchidism
Dosage : Female : Ovulation Induction : 5,000 -10,000 Units IM 1 day after the last dose of menotrphins.
Male :
Hypogonadotropic/Hypogonadismm :
Regimen 1 : 5000-10000 IM 3 times a week for 3 weeks, followed by the same dose twice a week for 3 weeks.
Regimen 2 : 4000 Units IM 3 times weekly for 6-9 months, after which the doses may be reduced to 2000 Units 3 times weekly for an additional 3 months.
Prepubertal Cryptorchidism :
Regimen 1 : 4000 units IM 3 times weekly for 3 weeks.
Regimen 2 : 5000 units every second day for 4 injections.
Regimen 3 : 15 Injections of 500-1000 units IM over a period of 6 weeks.
Regimen 4 : 500 units IM 3 weekly for 4-6 weeks.
Renally Impaired Patients : Safety and efficacy not established. Packing : 10 Vials of 10000 IU
|  | | |
| Choriotec |  | Choriotec (Chorionic Gonadotrophin For Injection BP 5000 IU0) Indications : Female :
- Anovulatory infertility
- Superovulation
- Corpus Luteum Insufficiency
- Habitual Abortion
- Threatened Abortion
Male :
- Hypogonadotropic hypogonadism
- Cryptorchidism
- Oligoasthenospermia
- Azoospermia
Dosage : Female: Anovulatory infertility : 5,000 I.U. or 10,000 I.U. given 24 - 48 hrs.
Superovulation : 10,000 IU of Choriotec is given in one single injection.
Corpus luteum Insufficiency : Up to 5000 I.U administered on the 5th day after ovulation and the same dose again on 9th day.
Habitual abortion / Threatened abortion :
Initial dose : 10,000 I.U.
Maintenance dose: 5000 I.U. twice weekly until (including) the 14th week of gestation.
MALE : Hypogonadotropic/Hypogonadismm :Choriotec 2000 I.U. should be given 2-3 times per week.
Cryptorchidism : Choriotec, 1000 I.U should be given on alternate days for several weeks .
Oligo-asthenospermia & azoospermia : Choriotec 2000 I.U. should be given every 5 days and Menotec 75-150 I.U. 3 times a week for three months.
Renally Impaired Patients : Safety and efficacy not established. Packing : 10 Vials of 5000 IU
| |
Choriotec | | Choriotec (Chorionic Gonadotrophin For Injection BP 2000 IU) Indications : Female :
- Anovulatory infertility
- Superovulation
- Corpus Luteum Insufficiency
- Habitual Abortion
- Threatened Abortion
Male :
- Hypogonadotropic hypogonadism
- Cryptorchidism
- Oligoasthenospermia
- Azoospermia
Dosage :
Female: Anovulatory infertility : 5,000 I.U. or 10,000 I.U. given 24 - 48 hrs.
Superovulation : 10,000 IU of Choriotec is given in one single injection.
Corpus luteum Insufficiency : Up to 5000 I.U administered on the 5th day after ovulation and the same dose again on 9th day.
Habitual abortion / Threatened abortion :
Initial dose : 10,000 I.U.
Maintenance dose: 5000 I.U. twice weekly until (including) the 14th week of gestation.
Male:
Hypogonadotropic/Hypogonadismm : Choriotec 2000 I.U. should be given 2-3 times per week.
Cryptorchidism :Choriotec, 1000 I.U should be given on alternate days for several weeks .
Oligo-asthenospermia & azoospermia :Choriotec 2000 I.U. should be given every 5 days and Menotec 75-150 I.U. 3 times a week for three months. Renally Impaired Patients : Safety and efficacy not established. Packing : 10 Vials of 2000 IU
|  | | |
| Clavox 375MG |  | (Amoxicillin And Clavulanate Potassium Tablets USP 375 mg) Indications : - Lower Respiratory Tract Infections
- Skin and Soft Tissue Infections
- Urinary Tract Infections
- Otitis media
- Sinusitis
Dosage : Adult : 1000 mg tablet every 12 hrs. 625 mg tablet every 8 hrs.
Pediatric : 30 mg /kg in divided dose.
Oral Dosage : 375 mg 8-12 hourly.
Really Impaired Patients : | CrCl (mL/min) | Recommended Dosage | | > 30 | No Change in dosage | | 10-30 | One 375mg tablet or one 625mg tablet 12 hourly | | <10 | Not more than one 375mg tablet 12 hourly 625mg tablets are not recommended | Packing : 3 Strips of 6 Tablets
| |
Clavox-New | | Clavox-New (Amoxicillin And Clavulanate Potassium Tablets USp 625 MG) Indications : Lower Respiratory Tract Infections Upper Respiratory Tract Infections Skin and Soft Tissue Infections Urinary Tract Infections Dosage : Adult : 1000 mg tablet every 12 hrs. 625 mg tablet every 8 hrs.
Pediatric : 30 mg /kg in divided dose.
Oral Dosage : 375 mg 8-12 hourly.
Renally Impaired Patients : | CrCl (mL/min) | Recommended Dosage | | > 30 | No Change in dosage | | 10-30 | One 375mg tablet or one 625mg tablet 12 hourly | | <10 | Not more than one 375mg tablet 12 hourly 625mg tablets are not recommended | Packing : 3 Strips of 6 Tablets
|  | | |
| Clavox-New |  | Clavox-New (Amoxicillin And Clavulanate Potassium Tablets USP 1000Mg) Indications : Lower Respiratory Tract Infections Upper Respiratory Tract Infections Skin and Soft Tissue Infections Urinary Tract Infections Dosage : Adult : 1000 mg tablet every 12 hrs. 625 mg tablet every 8 hrs.
Pediatric : 30 mg /kg in divided dose.
Oral Dosage : 375 mg 8-12 hourly.
Really Impaired Patients : | CrCl (mL/min) | Recommended Dosage | | > 30 | No Change in dosage | | 10-30 | One 375mg tablet or one 625mg tablet 12 hourly | | <10 | Not more than one 375mg tablet 12 hourly 625mg tablets are not recommended | Packing : 3 Strips of 4 Tablets
| |
Egycerin 250MG | | (Cycloserine 250mg Capsule)
Indications : Treatment of active pulmonary and extrapulmonary tuberculosis (including renal disease), when organisms are susceptible (after failure of adequate treatment with primary medications). Acute Urinary Tract Infections. Dosage : Adult : 500mg-1000 mg/day.
Paediatric : 10mg-20mg/kg/day (maximum daily dose: 1 g).
Active TB : 1 capsule (250 mg) BID/TID/QID.
Pulmonary TB : 1 capsule (250 mg) BID/TID/QID or 2 Capsules (500 mg) BID.
Really impaired patients :
| CrCl (mL/min) | Recommended Dosage | | 10-50 | Administer every 36-48 hours | | <10 | Administer every 36-48 hours | Packing : 1 Strip of 10 Caps
|  | | |
| Egytram 50MG |  | (Tramadol HCL 50mg Capsule)
Indications : Moderate to moderately severe pain. Dosage : Adults : 50 to 100mg can be administered as needed for pain relief every 4-6 hours not to exceed 400mg/day.
Paediatric : IV dose is1-2mg/kg. (Not recommended for infants below 2 yrs. Capsules and SR tablets are not recommended for use in children below the age of 12 years).
Renally impaired patients : In all patients with creatinine clearance less than 30 mL/min, it is recommended that the dosing interval should be increased to 12 hours, with a maximum daily dose of 200 mg. Packing : 1 Strip of 10 Caps.
| |
Egythram (Tramadol HCL Dispersible 50MG Tablet) | | Indications : Moderate to moderately severe pain. Dosage : Adults : 50 to 100mg can be administered as needed for pain relief every 4-6 hours not to exceed 400mg/day.
Paediatric : IV dose is1-2mg/kg. (Not recommended for infants below 2 yrs. Capsules and SR tablets are not recommended for use in children below the age of 12 years).
Renally impaired patients : In all patients with creatinine clearance less than 30 mL/min, it is recommended that the dosing interval should be increased to 12 hours, with a maximum daily dose of 200 mg. Packing : 1 Strip of 10 Tabs
|  | | |
| Egythram (Tramadol HCL 100MG SR Tablet) |  | Indications : Moderate to moderately severe pain. Dosage : Adults : 50 to 100mg can be administered as needed for pain relief every 4-6 hours not to exceed 400mg/day.
Paediatric : IV dose is1-2mg/kg. (Not recommended for infants below 2 yrs. Capsules and SR tablets are not recommended for use in children below the age of 12 years).
Renally impaired patients : In all patients with creatinine clearance less than 30 mL/min, it is recommended that the dosing interval should be increased to 12 hours, with a maximum daily dose of 200 mg. Packing : 1 Strip of 10 Tabs
| |
Egythram (Tramadol HCL 50mg Injection) | | Indications : Moderate to moderately severe pain. Dosage : Adults : 50 to 100mg can be administered as needed for pain relief every 4-6 hours not to exceed 400mg/day.
Paediatric : IV dose is1-2mg/kg. (Not recommended for infants below 2 yrs. Capsules and SR tablets are not recommended for use in children below the age of 12 years).
Really impaired patients : In all patients with creatinine clearance less than 30 mL/min, it is recommended that the dosing interval should be increased to 12 hours, with a maximum daily dose of 200 mg. Packing : 1 Amp of 50 mg\
|  | | |
| Egythram (Tramadol HCL 100MG Injection) |  | Indications : Moderate to moderately severe pain. Dosage :
Adults : 50 to 100mg can be administered as needed for pain relief every 4-6 hours not to exceed 400mg/day.
Paediatric : IV dose is1-2mg/kg. (Not recommended for infants below 2 yrs. Capsules and SR tablets are not recommended for use in children below the age of 12 years).
Renally impaired patients : In all patients with creatinine clearance less than 30 mL/min, it is recommended that the dosing interval should be increased to 12 hours, with a maximum daily dose of 200 mg. Packing : 1 Amp of 100 mg
| |
Ethipro 250MG | | (Ethionamide 250mg Tablets)
Indications : -
For the treatment of pulmonary and extra pulmonary tuberculosis in conjunction with other antituberculous agents (when resistance to primary agents has developed). -
For the treatment of leprosy, as part of multi-drug regimens. -
In the treatment of pulmonary disease in Mycobacterium kansasii and other atypical mycobacteria. Dosage : Adults : Tuberculosis : 15 to 20mg/kg/day.
Leprosy : 250 to 375 mg daily.
Paediatric Tuberculosis : 10-20mg/kg body weight daily to a maximum of 750 mg daily in divided doses.
Renally impaired patients : Dosage should be reduced to 250–500 mg daily in patients with creatinine clearance less than 30 mL/minute and in those undergoing hemodialysis. Packing : 1 Strip of 6 Tabs.
|  | | |
| Forzid-TZ 1.125G |  | (Ceftazidime Tazobactam: 1.125g Vials)
Indications : - Lower Respiratory Tract Infections
- Skin and Skin Structure Infections
- Urinary Tract Infections
- Pelvic Inflammatory Disease
- Bacterial Septicemia
- Bone & Joint Infections
- Intra-Abdominal Infections & Central Nervous System Infections.
Dosage : | Age Group | Infections | Dosage | | Adults | Most uses | 1g 8 hourly OR 2g 12-hourly | | Severe infections and infe in neutropenic patients | 2g 8 hourly OR 3g 12 hourly | | UTI | 500 mg 8 hourly OR 1g 12 hourly | | Prophylaxis for prostatectomy | 1g at induction ± 1g at catheter removal | | Cystic fibrosis | 100-150 mg/kg/day in two or three divided doses, not to exceed 9g/day | | Elderly | All infections, especially in those > 80 years | Not to exceed 3g daily total | | Infants > 2monts and children | Most uses | 30-100mg/kg/day in two or three divided doses | | Severe infections | Up to 150mg/kg/day (max 9g total per day) in three divided doses | | Neonates & infants <2 months | Most uses | 25-60mg/kg/day in two divided doses |
Recommended maintenance doses of FORZID_TZ in adults with renal insufficiency | Creatinine clearance ml/min | Usual Dose | Frequency dosing (hourly) | | 50-31 | 1 | 12 | | 30-16 | 1 | 24 | | 15-6 | 0.5 | 24 | | <5 | 0.5 | 4 |
Packing : 1 Vial of 1.125g
| |
Glugon (Glucagon For Injection USP 1 Mg) | | Indications : -
Severe hypoglycemia -
As a diagnostic aid Dosage : Adults : 1.0 mg SC / IM. Children (above 25 kg or 6-8 years) : 1.0 mg SC / IM.
Children (below 25 kg or 6-8 years) : 0.5 mg SC / IM.
The patient will normally respond within 10 minutes. When the patient responds to the treatment, give oral carbohydrate to restore the liver glycogen and prevent relapse of hypoglycaemia. If the patient does not respond within 10 minutes, intravenous glucose should be given.
Renally Impaired Patients : Not known, administer with caution. Packing : 10 Vials of 1 mg
|  | | |
| Hepagard (L-Ornithine-L-Aspartate Granules 5 G) |  | Indications : Dosage : Sachets : 1-2 Sachet (Dissolve in a glass of water) 3 times a day.
Renally Impaired Patients : Not known, administer with caution. Packing : 10 Sachets of 5 g
| |
Hepagard | | Hepagard (L-Ornithine-L-Aspartate Pancreatin Tablets 150 mg) Indications : Dosage : Tablets : 1-2 tablets 3 times a day for 3 months.
Maximum infusion rate : 5g / hr.
Renally Impaired Patients : Not known, administer with caution. Packing : 10 Strips of 10 Tablets
|  | | |
| Hepagard (L-Ornithine-l-Aspartate Infusion 5 G Or 10 Ml) |  | Indications : Dosage : Injection Adult : 4 amp. x 4 days or 8 amp. x 4 days and then 4 amp. x 3 days.
Maximum infusion rate : 5g / hr.
Renally Impaired Patients : Not known, administer with caution. Packing : 5 Ampoules of 10 ml
| |
Itzucia 100MG | | (Itraconazole 100mg Capsules)
Indications :
- In Pulmonary & aspergillosis
- Blastomycosis
- Febrile Neutropenia
- Histoplasmosis
- Onychomycosis
Dosage : | Indications | Adult Dosage | | Blastomycosis and Histoplasmosis | 200 mg OD (2 capsules). | | Aspergillosis | 200to 400 mg OD. | | Onychomycosis (Toenails with or without fingemail involvement) | 200 mg (2 capsules) OD for 12 consecutive weeks. | | Onychomycosis (Finger nails only) | 2 treatment pulses, each consisting of 200mg (2 capsules) BD (400 mg/day) for 1 week. The pulses are separated by a 3 week period without ltraconazole | | In Life-Threatening Situations | A loading dose of 200 mg (2 capsules) TID (600 mg/day) be given for the first 3 days of treatment | Paediatric : 5-10mg/kg/day as a single dose or divided into 2 doses. Renally impaired patients : CrCl <10 then decrease dose to 50%. Packing : 1 Strip of 8 Caps.
|  | | |
| Kezone (Cefoperazone For Injection 1G) |  | Indications : Bacterial septicaemia Dosage : Adult : 2g to 4g/day in 2 equally divided doses.
Pediatric : 50-200 mg/kg/day in 2 equally divided doses.
Renally Impaired Patients : No dosage adjustment required. Packing : 10 Vials of 1g
| |
Kezone 1G | | (Cefoperazone And Sulbactam For Injection 1 g (1:1))
Indications :
Dosage : Adult : 2g to 4g/day I.M or I.V B.I.D. maximum upto 8g/day.
Pediatric : 40-80 mg/kg/day in 2 to 4 divided doses.
Renally Impaired Patients : No dosage adjustment required. Packing : 1 Vial of 1g
|  | | |
| Kezone-S 2g |  | (Cefoperazone & Sulbactam 2g)
Indications : Dosage : Adult : 2g to 4g/day in 2 equally divided doses.
Pediatric: 50-200 mg/kg/day in 2 equally divided doses.
Renally Impaired Patients : No dosage adjustment required. Packing : 1 Vial of 2g
| |
Kezone-S (Cefoperazone & Sulbactam 1G Vials) | | Indications : -
Respiratory Tract Infections. -
Peritonitis and other intrabdominal infections. -
Bacterial septicaemia. -
Skin and Soft tissue infections. -
PID. -
Pre and post - operative prophylaxis. Dosage : Adult : 2 g to 4 g / day IM or IV B.I.D., maximum upto 8 g / day.
Paediatric : 40-80 mg / kg/ day in 2 to 4 divide doses.
Renally Impaired Patients : No dosage adjustment required. Packing : 1 Vial of 1gm
|  | | |
| Komitob 80MG |  | (Tobramycin 80mg Vials)
Indications : -
Lower Respiratory Tract Infections. -
Complicated and recurrent UTIs. -
Intra abdominal infections. -
Septicaemia. -
Serious CNS infections. - Nosocomial infections.
- Skin, bone & skin structure infections
Dosage : Adult : 3-5 mg/kg daily in 3 or 4 divided dose.
Paediatric : 6-7.5 mg/kg/day in 3 or 4 divided dose.
Renally impaired patients : | CrCl (ml/min) | Recommended dose | | >60 | Give every 8h | | 40-60 | Give every 12h | | 20-40 | Give every 24h | | 10-20 | Give every 49h | | <10 | Give every 48 -72h | High-dose (once daily) therapy: | CrCl (ml/min) | Recommended dose | | >60 | Usual dose | | <60 | Extend interval based on serum level determination |
Packing : 1 Vial of 80mg
| |
Komlinz 600MG | | (Linezolid 600mg Tablets)
Indications and Dosage :
Adult dose : In Vancomycin-resistant E. faecium infections Including Concurrent bacteremia : 600 mg oral every 12hr. for 14 to 28 days.
In Complicated skin and skin structure infections & Community-acquired Pneumonia, including Concurrent bacteremia : 600 mg oral every 12hr for 10 to 14 days.
In Uncomplicated skin and skin structure Infection : 600 mg oral every 12hr for 10 to 14 days. Packing : 1 Strip of 4 Tabs.
|  | | |
| Ofslog 200mg |  | (Ofloxacin Tablets USP 200 mg)
Indications :
- Lower Respiratory infections
- Urinary Tract infections
- Uncomplicated skin and skin structure infection
- Sexually transmitted disease
- Prostatitis
Dosage : | Infection | Unite Dose | Frequency | Duration | Daily Dose | | | | Every 12h | 10 days | 800mg | | | | Every 12h | 10 days | 800mg | | Uncomplicated Skin and Skin Structure Infections | 400mg | Every 12h | 10 days | 800mg | | Acute, Uncomplicated Urethritis and Cervical Gonorthea | 400mg | Single dose | 1 day | 400mg | | Nongonococcal Cervicitis/ Urethritis due to C. trachomatis | 300mg | Every 12h | 7 days | 600mg | | Acute Peivic Inflammatory Disease | 400mg | Every 12h | 10-14 days | 800mg | | Complicated UTI's | 200mg | Every 12h | 10 days | 400mg | | Prostatitis due to E.Coli | 300mg | Every 12h | 6 weeks | 600mg |
Really Impaired Patients : | CrCl (mL/min) | Recommended Dosage | | ≥50 | None | | 10-50 | ½ normal dose (1 tablet every 24 hours). | | ≤10 | 1/4 normal dose (1 tablet every 48 hours). | Packing : 10 Strips of 10 Tablets
| |
Ofslog (Ofloxacin Tablets USP 400 Mg) | | Indications : -
Gonorrhoea -
Lower Respiratory infections -
Urinary Tract infections -
Community acquired pneumonia -
Uncomplicated skin and skin structure infection -
Acute bacterial exacerbation of chronic bronchitis -
Acute pelvic inflammatory disease -
Sexually transmitted disease Dosage : | Infection | Unite Dose | Frequency | Duration | Daily Dose | | Acute Bacterial Exacerbation of Chronic Bronchitis | 400mg | Every 12h | 10 days | 800mg | | Comm. Acquired Pneumonia | 400mg | Every 12h | 10 days | 800mg | | Uncomplicated Skin and Skin Structure Infections | 400mg | Every 12h | 10 days | 800mg | | Acute, Uncomplicated Urethritis and Cervical Gonorthea | 400mg | Single dose | 1 day | 400mg | | Nongonococcal Cervicitis/ Urethritis due to C. trachomatis | 300mg | Every 12h | 7 days | 600mg | | Acute Peivic Inflammatory Disease | 400mg | Every 12h | 10-14 days | 800mg | | Complicated UTI's | 200mg | Every 12h | 10 days | 400mg | | Prostatitis due to E.Coli | 300mg | Every 12h | 6 weeks | 600mg | Really Impaired Patients : | CrCl (mL/min) | Recommended Dosage | | ≥50 | None | | 10-50 | ½ normal dose (1 tablet every 24 hours). | | ≤10 | 1/4 normal dose (1 tablet every 48 hours). | Packing : 10 Strips of 10 Tablets
|  | | |
| Pantazol 40mg |  | (Pantoprazole Tablets 40 mg)
Indications :
Dosage :
GERD : 40mg once daily upto 8 weeks.
Zollinger Ellison Syndrome : Starting dose is 40 mg twice daily. Doses should be adjusted according to patient. Erosive Esophagitis : 40mg taken daily. Packing : 10 Strips of 10 Tablets
| |
Pantazol 40MG | | (Pantoprazole For Injection 40 mg)
Indications :
Dosage :
GERD & Erosive Esophagitis : 40mg given once daily by intravenous infusion for 7 to 10 days.
Zollinger Ellison Syndrome : 80mg q 12 hrs.
Renally Impaired Patients : No dosage adjustment required. Packing : 1 Vial of 40mg
|  | | |
| Ribapro 200MG |  | (Ribavirin 200mg Capsule)
Indications : - Chronic Hepatitis B
- Chronic Hepatitis C virus
- In patients previously untreated with alpha interferon
- In patients who have relapsed following alpha interferon therapy
Dosage : Ribavirin must be used in combination with either peginterferon alfa-2b or interferon alfa-2b.
The dose of Ribavirin is based on patient body weight.
Ribavirin capsules are to be administered orally each day in two divided doses (morning and evening) with food.
Adults : The dose of Ribapro is based on patient body weight.
Ribapro must be used in combination with either peginterferon alfa-2b (1.5 micrograms/kg/week) or interferon alfa-2b (3 million international units [MIU] three times a week). The choice of combination regimen is based on the characteristics of the patient. | Patient Weight (kg) | Daily RIBAPRO Dose | Number of 100mg capsules | Number of 200mg capsules | | <65 | 800 mg | 8 (4 morning, 4 evening) | 4 (2 morning,2 evening) | | 65-85 | 1,000 mg | 10 (4 morning, 6 evening) | 5 (2 morning, 3 evening) | | 81-105 | 1,200 mg | 12 (6 morning, 6 evening) | 6 (3 morning, 3 evening) | | >105 | 1,400 mg | 14 (6 morning, 8 evening) | 7 (3 morning, 4 evening) | Children 3 years of age & older and adolescents : Dosing for children and adolescent patients is determined by body weight for Ribavirin and by body surface area for peginterferon alfa-2b and interferon alfa-2b. Packing : 1 Strip of 8 Caps.
| |
T-Pressin 1MG | | (Terlipressin Injection 1mg)
Indications : -
Variceal haemorrhage -
Hepatorenal syndrome -
Shock
Dosage : Variceal Haemorrhage : 2mg every 4-6 hours by IV inj. The treatment should continue until bleeding has been controlled for 24 consecutive hours or for a maximum period of 72 hours.
Hepatorenal Syndrome : 1-3mg/day for 7-15 days.
Shock : IV bolus of 1 to 2 mg.
Renally Impaired Patients : Not known, administer with caution.
Packing : 5 Ampoules of 1.0 mg/10 ml
|  | | |
| U-Fixim 200mg |  | (Cefixime Tablets USP 200 mg)
Indications : - Upper Respiratory Tract Infections
- Lower Respiratory Tract Infections
- Uncomplicated Urinary Tract Infection
- Uncomplicated gnorrhea
- Otitis media
Dosage : Adult : 200-400mg/day as a single or in two divided doses.
Paediatric : 8mg/kg/ day as a single or in two divided doses.
Renally Impaired Patients :
| CrCl(ml/min) | Recommended Dosage | | >60 | 400mg/day | | 21-60 | 300mg/day |
| 200mg/da |
Packing : 5 Strips of 4 Tablets
| |
U-Fixim 100MG | | (Cefixime DT Tablets USP 100 mg)
Indications : Dosage : Adult : 200-400mg/day as a single or in two divided doses.
Paediatric : 8mg/kg/ day as a single or in two divided doses.
Renally Impaired Patients :
| CrCl(ml/min) | Recommended Dosage | | >60 | 400mg/day | | 21-60 | 300mg/day | | | 200mg/da | Clinical Pharmacology: Beta Lactam Packing : 5 Strips of 4 Tablets
|  | | |
| Unidom-DT(Domperidone Dispersible Tablets 10 MG) |  | Indications : -
Prevention and symptomatic relief of acute nausea and vomiting from any cause including cytotoxic therapy, radio therapy and anti – parkinsonism -
Stimulation of gut mobility -
Non ulcer dyspepsia -
Esophageal reflux, Reflux Esophagitis and Gastritis -
Diabetic gastroparesis -
Functional dyspepsia -
Speeding barium transit in “follow – through” radiological studies -
In the treatment of migraine Dosage : Acute conditions (mainly nausea, vomiting, hiccup) Adults : Two tablets (20 mg) 3 to 4 times per day.
Children 5 to 12 years old : One tablet (10 mg) 3 to 4 times per day.
Nausea / vomiting associated with dopamine agonist Anti – Parkinson agent : 20 mg 3-4 times / day.
Chronic conditions (mainly dyspepsia) Adults : One tablet (10 mg) taken 3 times per day. The dosage may be doubled as per need.
Children 5 to 12 years old : ½ tablet (5 mg) 3 to 4 times per day.
Migraine : 20 mg every 4 hourly in combination with paracetamol.
Renally Impaired Patients : In patients with severe renal insufficiency (creatinine serum levels > 6 mg/100mL, the elimination half-life of domperidone was increased from 7.4 to 20.8 hours. Administer with Caution. Packing : 10 Strips10 Tablets
| |
Uniraut 100MG | | (Iron Sucrose Injection USP 100 mg / 5 ml)
Indications :
Iron defeciency anaemia in :
- Non dialysis dependent chronic kidney disease
- Postpartum anemia and postpartum haemorrhage
- Patients with poor iron absorption (bowel operations or diseases)
- Patients with severe renal impairment
Dosage : The total cumulative dose of iron sucrose, equivalent to the total iron deficit (mg), is determined by the hemoglobin level and body weight.
Adult : 100-200mg iron one-three times a week depending on the Hb level.
Children : 30mg/kg body wt. one-three times per week depending on the Hb level.
Dosage Adjustment :
Renal Impairment : Administer with caution in severe renal impairment.
Hepatic Impairment : Required. Packing : 5 Ampoules of 5 ml
|  | | |
| Uniraut 50MG |  | (Iron Sucrose Injection USp 50mg / 2.5ml)
Indications : -
Pre existing (moderate to severe) anemia -
Patients not responding or having poor compliance with oral iron supplements -
Pre and postoperative period -
Postpartum anemia and postpartum haemorrhage -
Patients with poor iron absorption (bowel operations or diseases) -
Patients with severe renal impairment
Dosage : The total cumulative dose of iron sucrose, equivalent to the total iron deficit (mg), is determined by the hemoglobin level and body weight.
Adult : 100-200mg iron one-three times a week depending on the Hb level.
Children : 30mg/kg body wt. one-three times per week depending on the Hb level.
Dosage Adjustment :
Renal Impairment : Administer with caution in severe renal impairment.
Hepatic Impairment : Required. Packing : 5 Ampoules of 2.5 ml
| |
Unitrax-TZ 1.125G | | (Ceftriaxone Sodium Plus Tazobactam : 1.125g Vials)
Indications : - Lower Respiratory Tract Infections
-
Acute Bacterial Otitis Media -
Skin and Skin Structure Infections -
Urinary Tract Infections -
Uncomplicated Gonorrhea -
Pelvic Inflammatory Disease -
Bacterial Septicemia -
Bone and Joint Infections -
Intra-Abdominal Infections -
Meningitis -
Surgical Prophylaxis
Dosage : Adults :
Usual dose: 1.125 to 2.250 grams given once a day (or in equally divided doses twice a day) depending on the type and severity of infection.
Surgical Prophylaxis : A single dose of 1.125 gram administered intravenously ½ to 2 hours before surgery. Children :
Skin and skin structure infections: 56.25 to 84.375 mg/kg of UNITRAX-TZ given once a day (or in equally divided doses twice a day).
Acute bacterial otitis media: 56.25 mg/kg of UNITRAX-TZ given single IM dose. Serious miscellaneous infections other than meningitis: 56.25 to 84.375 mg/kg of UNITRAX-TZ, given in divided doses every 12 hours.
Meningitis: 112.5 mg/kg of UNITRAX-TZ given as initial therapeutic dose. Packing : 1 Vial of 1.125g
|  | | |
| Vasmed 20 I.U. |  | (Vasopressin 20 I.U. / 1ml Amp)
Indications :
Dosage : Adults :
Abdominal roentgenography : 2 Inj. of 10 Units (0.5ml) SC or IM
Abdominal Distention : 5 units (0.25 ml) initially, increase to 10 units (0.5 ml) to be given IM & repeat injection as required.
Diabetes Insipidus : 5- 10 units (0.25- 0.5 ml) IM/ SC 2-3 times daily.
Children :
Abdominal Distention : dosage to be reduced proportionately.
Diabetes Insipidus : 2.5- 10 units IM/ SC 2-4 times daily
Really impaired patients : Not known, administer with caution.
Hepatically impaired patients : Required, administer with caution. Packing : 5 Amp of 20 units / 1ml
| |
Vonaz 50MG | | (Voriconazole Tablets 50 mg)
Indications :
Dosage : | Infections | Loading Dose | Maintenance Dose | | IV | IV | ORAL | | Invasive Aspergillosos | 6 mg/kg q 12h for the first 24 hours | 4 mg/kg q 12h | 200 mg q 12h | | Candidemia in non-neutropenic patients & other deep tissue Candida infections | 6 mg/kg q 12h for the first 24 hours | 3-4 mg/kg q 12h | 200 mg q 12h | | Esophageal Candidaiasis | | | 200 mg q12h | | Scedosporiosis and Fusariosis | 6 mg/kg q 12h for the first 24 hours | 4 mg/kg q 12h | 200 mg q 12h | | Patients who weight 40 kg or more should receive an oral maintenance dose of 200 mg VONAZ every 12 hours. Adult patients who weigh less than 40 kg should received an oral maintenance dose of 100 mg every 12 hours |
Paediatric (For age 2 to <12 years) : Not recommended for use in children below 2 years. | | Intravenous | Oral | | Loading Dose Regimen | No oral or intavenous | Loading dose is recommended | | Maintenance Dose | 7 mg/kg twice daily | 200 mg twice daily | Paediatric (2-12 Years) : | | INTRAVENOUS | ORAL | | Loading Dose Regimen | No Oral or intravenous loading dose is recommended | | Maintenance Dosse | 7 mg/kg twice daily | 200 mg twice daily |
Renally Impaired Patients : No dosage adjustment required. Packing : 5 Strips of 4 Tablets
|  | | |
| Vonaz 200MG |  | (Voriconazole For Injection 200 mg)
Indications :
Dosage : | Infections | Loading dose | Maintenance dose | | IV | IV | ORAL | | Invasive Aspergillosos | 6 mg/kg q 12h for the first 24 hours | 4 mg/kg q 12h | 200 mg q 12h | | Candidemia in non-neutropenic patients & other deep tissue Candida infections | 6 mg/kg q 12h for the first 24 hours | 3-4 mg/kg q 12h | 200 mg q 12h | | Esophageal Candidaiasis | | | 200 mg q12h | | Scedosporiosis and Fusariosis | 6 mg/kg q 12h for the first 24 hours | 4 mg/kg q 12h | 200 mg q 12h | | Patients who weight 40 kg or more should receive an oral maintenance dose of 200 mg VONAZ every 12 hours. Adult patients who weigh less than 40 kg should received an oral maintenance dose of 100 mg every 12 hours |
Paediatric (For age 2 to <12 years) : Not recommended for use in children below 2 years. | | Intravenous | Oral | | Loading Dose Regimen | No oral or intavenous | Loading dose is recommended | | Maintenance Dose | 7 mg/kg twice daily | 200 mg twice daily | Paediatric (2-12 Years) : | | Intravenous | Oral | | Loading Dose Regimen | No Oral or intravenous loading dose is recommended | | Maintenance Dosse | 7 mg/kg twice daily | 200 mg twice daily |
Renally Impaired Patients : No dosage adjustment required. Packing : 4 Vials of 200 mg
| |
|

|